February 19, 2024

Breaking Ground: MAPS PBC Submits First NDA to FDA for Psychedelic-Assisted Therapy

Written By: Dr. Joao De Quevedo In a historic leap forward for the field of mental health, the Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation (PBC) has achieved a groundbreaking milestone by submitting the first New Drug Application…


February 5, 2024

A Ray of Hope: FDA Approves Zuranolone for Postpartum Depression

Written By: Dr. Joao De. Quevedo In a groundbreaking moment for mental health, the Food and Drug Administration (FDA) has recently approved Zuranolone, a novel medication, to treat postpartum depression (PPD). This decision marks a significant step forward in addressing…


January 29, 2024

A New Dawn: FDA Greenlights Exxua (Gepirone ER) for Major Depressive Disorder

Written By: Dr. Joao De Quevedo In a significant stride towards advancing mental health treatment, the U.S. Food and Drug Administration (FDA) has recently approved Gepirone ER, a promising medication now available under the brand name Exxua. This breakthrough offers…


January 23, 2024

Bipolar Disorder

Written By: Dr. Joao De Quevedo What is bipolar disorder? Bipolar disorder, also known as manic-depressive illness, is a psychiatric condition that causes unusual shifts in mood state, sleep, energy and activity levels. The person can have a period of…


January 8, 2024

SEASONAL AFFECTIVE DISORDER

Written By: Dr. Joao De Quevedo What is seasonal affective disorder? Seasonal Affective Disorder (SAD) is a type of depression that follows a seasonal pattern. It is a mood-related condition that affects almost 5% of the U.S. population annually and…


January 2, 2024

The Genetics of Depression: Unraveling the Molecular Tapestry

Written by Dr. Joao De Quevedo Depression, a prevalent and debilitating mental health disorder, has long been recognized as having a multifactorial etiology, with genetic factors playing a substantial role. This essay delves into the intricate interplay between genetics and…


December 15, 2023

A Holiday Interview with Dr. Taiwo Babatope

An interview with Taiwo Babatope, MD: What are your thoughts on holiday traditions for children and families – like Christmas/Hannukah? Holiday traditions for children and families, such as Christmas and Hannukah celebrations, are deeply significant social rituals that go beyond…


December 11, 2023

The Serotonin Basis of Depression: Unraveling the Neurochemical Web

Written By: Dr. Joao L. de Quevedo, MD, PhD Depression, a pervasive and debilitating mental health disorder, has long been a subject of scientific inquiry. Among the myriad factors contributing to its complex etiology, serotonin, a neurotransmitter, has emerged as…


November 28, 2023

Pharmacogenetics-Guided Treatment for Depression: A Personalized Approach to Mental Health

Written by: Joao L. de Quevedo, MD, PhD Depression is a complex mental health disorder affecting millions worldwide, with a myriad of contributing factors ranging from genetic predispositions to environmental stressors. Traditional approaches to treating depression often involve a trial-and-error method,…


November 21, 2023

FDA Approval of Transcranial Magnetic Stimulation (TMS) for Obsessive-Compulsive Disorder (OCD)

Written by: Joao L. de Quevedo, MD, PhD The Food and Drug Administration (FDA) approval of transcranial magnetic stimulation (TMS) for the treatment of obsessive-compulsive disorder (OCD) marks a pivotal moment in the intersection of neuromodulation and mental health care….


Pages